HerbalNomics Inc

𝑬𝒎𝒑𝒐𝒘𝒆𝒓𝒊𝒏𝒈 𝑶𝒖𝒓 𝑪𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚 𝒘𝒊𝒕𝒉 𝑰𝒏𝒇𝒐𝒓𝒎𝒂𝒕𝒊𝒐𝒏
🌱🌱🌱🌱🌱🌱🌱🌱🌱
HerbalNomics is a non-profit organization based in Atlanta, GA that provides education and training on the safe and responsible use of cannabis.

🌱🌱🌱🌱🌱🌱🌱🌱



Need assistance with obtaining you Medical Cannabis Card? Click the link in our bio!

HerbalNomics Inc is a Georgia Non-Profit State-Certified and Licensed Live Plant Grower, focused on research, clinical trials, and studies for cannabis CBD. We specialize in the production of organic cannabis plants as well as hybrid cannabis strains.

Herbalnomics HerbalNomics is a non profit organization whose mission is to educate and empower communities with Cannabis Research Cannabis Clinical studies

This is great news for Georgia’s Patients 🙏🏿🙏🏿

ADEL – The Adel-Cook County Chamber of Commerce will hold a ribbon-cutting ceremony for the city’s new medical cannabis dispensary. Trulieve Cannabis Corp, one of the leading cannabis companies in the U.S., will hold the event at its indoor production plant at 355 S. Cook Industrial Parkway, 11 a.m. Friday, Dec. 2. According to Trulieve representatives, expected attendees include members of the Georgia Access to Medical Cannabis Commission, state legislators and local business leaders. Kim Rivers, chief executive officer of Trulieve, said the GMCC's decision solidifies and expands Trulieve's Southeastern hub and will introduce the company's products to Georgia's developing medical cannabis market. "Trulieve is proud to open the doors of our Georgia production facility to community leaders, legislators and the Georgia Access to Medical Cannabis Commission who made this possible. We look forward to providing medical cannabis to patients in need and introducing our high-quality and safe products in the state’s growing medical cannabis market,” she said. The new facility will produce a variety of low-THC oil products in both oral and topical forms that will be available to patients at Trulieve’s initial medical cannabis dispensaries throughout Georgia. Dr. Lisa Pinkey, president of Trulieve GA, Inc., said the company is happy to finally start expanding in Georgia. “The Georgia team is excited to debut our facilities. We have been hard at work to begin operations in the most safe and efficient manner to ensure those in need have access to Trulieve’s products. We are proud to bring jobs and economic development to South Georgia and to educate the Georgia medical community on the potential benefits of cannabis for patients with qualifying conditions,” she said. Read full article https://www.valdostadailytimes.com/news/adel-to-debut-cannabis-facility/article_c8de6336-7028-11ed-9104-a7002a4beb5f.html #GeorgiaCannabis #MedicalCannabis #Trulieve

This is great news for Georgia Patients 🙏🏿🙏🏿

ADEL – The Adel-Cook County Chamber of Commerce will hold a ribbon-cutting ceremony for the city’s new medical cannabis dispensary. Trulieve Cannabis Corp, one of the leading cannabis companies in the U.S., will hold the event at its indoor production plant at 355 S. Cook Industrial Parkway, 11 a.m. Friday, Dec. 2. According to Trulieve representatives, expected attendees include members of the Georgia Access to Medical Cannabis Commission, state legislators and local business leaders. Kim Rivers, chief executive officer of Trulieve, said the GMCC's decision solidifies and expands Trulieve's Southeastern hub and will introduce the company's products to Georgia's developing medical cannabis market. "Trulieve is proud to open the doors of our Georgia production facility to community leaders, legislators and the Georgia Access to Medical Cannabis Commission who made this possible. We look forward to providing medical cannabis to patients in need and introducing our high-quality and safe products in the state’s growing medical cannabis market,” she said. The new facility will produce a variety of low-THC oil products in both oral and topical forms that will be available to patients at Trulieve’s initial medical cannabis dispensaries throughout Georgia. Dr. Lisa Pinkey, president of Trulieve GA, Inc., said the company is happy to finally start expanding in Georgia. “The Georgia team is excited to debut our facilities. We have been hard at work to begin operations in the most safe and efficient manner to ensure those in need have access to Trulieve’s products. We are proud to bring jobs and economic development to South Georgia and to educate the Georgia medical community on the potential benefits of cannabis for patients with qualifying conditions,” she said. Read full article https://www.valdostadailytimes.com/news/adel-to-debut-cannabis-facility/article_c8de6336-7028-11ed-9104-a7002a4beb5f.html #GeorgiaCannabis #MedicalCannabis #Trulieve

Do you need a Medical Cannabis Card? Are you a Georgia resident? Send us a email [email protected] call us (404)527-6247 or dm us on IG. Cannabis is a essential medication......

Don’t forget to wear blue tomorrow! Join in on National Human Trafficking Awareness Day and post a photo of yourself, friends, colleagues, or family wearing blue clothing to raise awareness of human trafficking. You can participate through social media platforms using the hashtag , and follow the conversation. Together, we can end trafficking. January 11, 2020

Come in Georgia 🤷🏿‍♀️

Georgia’s new medical ma*****na program stalls 6 months after law signed Six months after Gov.

Must read.

Gene linked to autism undergoes changes in men's s***m after cannabis use - Neuroscience News Ma*****na use alters a gene associated with autism in s***m. Hypomethylation was identified in the DLGAP2 gene in the s***m of male rats exposed to THC. The hypomethylated state was also detected in the forebrains of their offspring. Further research is needed to establish if there is a definitive l...

Notice of Intent to Consider the Adoption of H**p Growers and Processors Rules
On May 10, 2019, Georgia Governor Brian Kemp signed HB 213 authorizing the Georgia Department of Agriculture (GDA) to regulate the cultivation, processing, and handling of h**p in the State of Georgia. The “Georgia H**p Farming Act” requires GDA to develop rules and regulations for the regulation of h**p production in Georgia.
Pursuant to the Official Code of Georgia Annotated, O.C.G.A. §§ 2-23-12 and 50-13-4, notice is hereby given that the Georgia Department of Agriculture will be accepting written comments regarding the adoption of H**p Growers and Processors Rules from July 10, 2019, to the close of business (4:30 p.m. EST) on August 12, 2019. The proposed rules and further directions on commenting can be found at http://agr.georgia.gov/2019-legal-notices.aspx.

Under the U.S. Drug Enforcement Administration’s (DEA) Controlled Substance Act (CSA), drugs are classified into five distinct schedules depending upon their acceptable medical use and their overall potential for abuse or dependency. The DEA currently lists cannabis as a Schedule I drug, which the CSA defines as drugs having no currently accepted medical use and a high potential for abuse. It appears, however, that the DEA may soon reconsider its current Schedule I classification of cannabis.

This article considers how the DEA’s potential reclassification of cannabis potentially could affect Georgia’s medical cannabis industry. Specifically, the article discusses: (1) how Georgia medical cannabis distributors would operate within this new regulatory framework; (2) how this change would affect registered Georgia patients who are either currently purchasing medical cannabis or are planning to do so; and (3) whether this reclassification would cause big pharmaceutical companies to enter Georgia’s medical cannabis market, and if so, how.

The DEA’s Reclassification of Cannabis Would Likely Affect the Regulatory Framework of Georgia’s Medical Cannabis Industry
On April 2, 2019, Georgia became the 34th U.S. state to legalize cannabis for medicinal use when the Georgia Legislature passed House Bill 324 (“HB 324”), which recently took effect on Monday, July 1, 2019. In Georgia, medical cannabis is defined as a “low-THC oil” that contains 5% or less of tetrahydrocannabinol (THC)—the psychoactive chemical in cannabis that causes a “high.”

Georgia State Flag
If the DEA reclassifies cannabis, the regulatory framework of Georgia’s medical cannabis industry under HB 324 would likely be affected. For instance, depending on how the DEA elects to reclassify cannabis, low-THC oil products manufactured and sold in Georgia could become subject to the U.S. Food and Drug Administration’s (FDA) costly, complicated and time-consuming drug approval process. Then, any low THC oil products that the FDA approves will be subject to federally mandated quality, efficacy and potency standards for FDA-approved drugs. Also, any federal standards that stem from the DEA’s reclassification of cannabis will trump any conflicting provisions in HB 324 or any other conflicting rules, regulations or procedures established by the Georgia Access to Medical Cannabis Commission (GAMCC), the seven member state agency responsible for promulgating and implementing the state-based rules, regulations and procedures necessary to produce and distribute low-THC oil in Georgia, and the Georgia State Board of Pharmacy (Pharmacy Board). However, even if the DEA reclassifies cannabis, the following state regulatory framework established by HB 324 will remain unaffected:

The GAMCC will likely continue to oversee the state’s medical cannabis industry.
The following two different types of dispensary licenses issued under the legislation will still likely remain: retail outlets (issued by the GAMCC) and pharmacies (issued by the Pharmacy Board).
Licensed dispensaries will still likely not be located within a 1,000-foot radius of a school or church, and licensed production facilities will still not be located within a 3,000-foot radius of a school or church.
Pharmacists who dispense low-THC oil will still likely have to review each registered patient’s information on the state’s Prescription Drug Monitoring Program (PDMP) database to confirm that they have been diagnosed with one or more of the 17 approved conditions and diseases. The legislation does not require retail outlet dispensaries to review patient information on the PDMP database or employ a pharmacist to dispense the drug.
Registered patients will still likely be prohibited from va**ng low-THC oil or inhaling it by any other electronic means. The legislation does not expressly prohibit the use of other, non-electronic delivery methods of low THC oil such as pills or nasal spray.
All licensed dispensaries (and all licensed production companies) will still likely be subject to an “on-demand” inspection when requested by the Georgia Bureau of Investigation (GBI), the GAMCC, the four-member Medical Cannabis Commission Oversight Committee (MCCOC), or local law enforcement. The GAMCC and the Georgia Drugs and Narcotics Agency (GDNA) will also still likely be able to conduct one, annual inspection of dispensary locations. And, upon request, licensed dispensaries will still likely be required to immediately provide a sample of their low-THC oil for laboratory testing to the GBI, GAMCC, MCCOC, GDNA or local law enforcement.
All licensed dispensaries (and all licensed production facilities) will still likely be required to utilize a GAMCC-approved seed-to-sale tracking software.
All licensed dispensaries (and all licensed production companies) will still likely be prohibited from advertising or marketing their low-THC oil products to registered patients or the public. However, they will still likely be allowed to provide information about their products directly to physicians, and upon request, physicians will still likely be allowed to furnish the names of licensed dispensaries (and licensed production companies) to registered patients or their caregivers.
The DEA’s Reclassification of Cannabis Would Likely Affect the Availability of Low THC Oil
To date, approximately 9,500 Georgians are registered with the state’s Low-THC Registry, which allows them to purchase low-THC oil from licensed dispensaries. Since the legislation’s passage, the number of registered patients has increased significantly and continues to steadily rise. If the DEA reclassifies ma*****na, this patient number will likely increase at an even faster rate because the public will likely perceive reclassification as an acknowledgement by the federal government that ma*****na possesses health and medicinal benefits. If that occurs, statewide demand for low THC oil could quickly outstrip the supply.

Georgia Gov. Brian Kemp
Image: Georgia National Guard, Flickr
Under HB 324, the GAMCC is tasked with ensuring that the state has a sufficient number of retail outlet dispensaries across the state to meet patient demand but is limited to issuing only six production licenses. As the number of registered patients continues to grow, the GAMCC may be forced to recommend amendments to the statute allowing it to issue additional production licenses to increase the state’s supply of low THC oil, and depending on how many additional patients are added to the state’s Low-THC Registry, the GAMCC may also have to issue additional dispensary licenses to keep up with patient demand by relaxing the geographic limitations on locating dispensaries.

Thus, the DEA’s reclassification of cannabis likely would affect the amount of low THC oil available to registered patients in Georgia.

The DEA’s Reclassification of Cannabis Would Likely Cause Large Pharmaceutical Companies to Enter Georgia’s Medical Cannabis Market
Large pharmaceutical companies typically manufacture, market, sell and ship their products on a national and international scale. Given cannabis’ current status as a Schedule I drug under the CSA, these companies have largely steered clear of the burgeoning medical ma*****na industry because of the inherent risk of violating federal law. If the DEA reclassifies cannabis, that risk will be diminished greatly, and the companies therefore will likely decide to enter the market by acquiring existing medical ma*****na companies with established national or state-level medical cannabis brands.

If the DEA reclassifies cannabis, Georgia’s medical cannabis market will likely be affected in multiple ways.Depending on how the DEA reclassifies cannabis, low-THC oil in Georgia could be subject to stringent federal standards, including the FDA’s complex and expensive drug approval process. Georgia medical cannabis companies will likely not be accustomed to complying with such federal regulations. Large pharmaceutical companies, on the other hand, are very accustomed to dealing with the federal government, including FDA drug approval. So, if the DEA reclassifies ma*****na, pharmaceutical companies will likely view reclassification as a tremendous opportunity to enter the Georgia market by leveraging their experience and institutional knowledge dealing with federal law to acquire or partner with a licensed Georgia cannabis company that has an established brand of low -HC oil.

Entering Georgia’s medical cannabis market won’t be easy, however, because HB 324 prohibits licensees from transferring their licenses for five years and requires that the original licensee be a Georgia business. But, HB 324 does not prohibit them from selling their businesses, which necessarily includes any licenses the business owns. Purchasing a licensed Georgia medical cannabis company requires payment of a production license business transfer fee. The fee for the first sale of a business with a Class 1 production license is $100,000 and the fee for a Class 2 license is $12,500. The fee for the second sale is $150,000 for a Class 1 production license, and $62,500 for a Class 2 license. The fee for the third and fourth sales is $200,000 for a Class 1 production license, and $112,500 for a Class 2 license.

Conclusion
If the DEA reclassifies cannabis, Georgia’s medical cannabis market will likely be affected in multiple ways. Specifically, depending on how the drug is reclassified, the regulatory framework for medical cannabis companies likely will change to include both state and federal requirements, potentially including the FDA’s complex drug approval process. Also, the amount of low-THC oil available for registered patients to purchase likely will be diminished precipitating the need for the GAMCC to modify the statute to allow for issuing additional production licenses and relaxing the geographic limitations on locating dispensaries. Finally, large pharmaceutical companies likely will attempt to enter Georgia’s medical cannabis market by purchasing existing, licensed Georgia companies that have established low-THC oil brands.

Cannabis and Autism: What’s Next?

The overall impact of this study is significant. Not only is it the first study to scientifically evaluate the effect of cannabis on ASD, but the results were largely positive.

The results were so promising that the researchers are planning a larger follow-up study with 100 participants. The follow-up study will further explore the potential of cannabis to treat children living with severe, ASD-related behavior problems.

The researchers are careful to conclude that, while they are optimistic about their results, more controlled, clinical trials with higher numbers of participants are needed before physicians can begin prescribing cannabis or CBD for the treatment of ASD.

Another important point to make is that cannabis extracts with higher concentrations of THC, the main psychoactive compound in cannabis that can cause anxiety, can potentially make behavioral symptoms worse. This is why the follow-up studies will continue to use CBD-rich cannabis as well as Cannabidivarin (CBDV), a cannabis-based cannabinoid that is similar to CBD.

Given the historic FDA approval of CBD for the treatment of severe epilepsy, it’s possible we could see the approval of cannabis oil or CBD for the treatment of autism in the next several years.

In 2018 nearly 50,000 people died because of opioid overdose. Big pharmacy is pumping communities with addictive opioids. Creating a opioid dependencies problem. The earth provides us with cures and remedies to most ailments. Know the deal before you start poppin pills medicine.....

If your pets can tell how they love and thankful to CBD. They maybe jumping with joy for choosing CBD😉💚✅🍀

If you have relatives or friends who suffers cancer, walk with them! Our team will always encourage you to fight cancer with CBD💚

We can help you with your recommendation!!!! We’re working directly with a Doctor to help get you on the registry. DM us or email us at [email protected] for more information.

We also have great articles for you to read just visit us at www.herbalnomicsinc.org. We are still accepting volunteers please visit our page and click the sign up button.

*****na

CBD for Cats With Diabetes | herbalnomics mage blood vessels, which some sources suggest could be caused by chronic inflammation as a result of high blood sugar levels. Infections: Cats with diabetes te...

If your pets have this condition, go for CBD😉💚✅🍀

If you have relatives or friends who suffers cancer, walk with them! Our team will always encourage you to fight cancer with CBD💚

We can help you with your recommendation!!!! We’re working directly with a Doctor to help get you on the registry. DM us or email us at [email protected] for more information.

We also have great articles for you to read just visit us at www.herbalnomicsinc.org. We are still accepting volunteers please visit our page and click the sign up button.

*****na

CBD and Diabetic Pets | herbalnomics All About CBD Oil for Pets  Pet owners naturally want to do anything and everything they can to keep their animals in glowing health. If you're the owner of a d...

CBD will always show his potential especially in saving people live and giving hope to survive😉💚✅🍀

If you have relatives or friends who suffers cancer, walk with them! Our team will always encourage you to fight cancer with CBD💚

We can help you with your recommendation!!!! We’re working directly with a Doctor to help get you on the registry. DM us or email us at [email protected] for more information.

We also have great articles for you to read just visit us at www.herbalnomicsinc.org. We are still accepting volunteers please visit our page and click the sign up button.

*****na

Are you dealing with this? Dial CBD now for the amazing care you needed😉💚✅🍀

If you have relatives or friends who suffers cancer, walk with them! Our team will always encourage you to fight cancer with CBD💚

We can help you with your recommendation!!!! We’re working directly with a Doctor to help get you on the registry. DM us or email us at [email protected] for more information.

We also have great articles for you to read just visit us at www.herbalnomicsinc.org. We are still accepting volunteers please visit our page and click the sign up button.

*****na

"Cannabis compounds could help to control a patient’s blood sugar" This fact sounds music to all suffering from Diabetes. Do you wanna left behind? Try CBD now!😉💚✅🍀

If you have relatives or friends who suffers cancer, walk with them! Our team will always encourage you to fight cancer with CBD💚

We can help you with your recommendation!!!! We’re working directly with a Doctor to help get you on the registry. DM us or email us at [email protected] for more information.

We also have great articles for you to read just visit us at www.herbalnomicsinc.org. We are still accepting volunteers please visit our page and click the sign up button.

*****na

HOW CANNABIS OIL CAN BE USED FOR DIABETES TREATMENT AND PREVENTION | herbalnomics Diabetes is a widespread disease inflicting millions of people worldwide. Chances are you know someone, either in your family or in your circle of friends, who ...

CBD for Diabetes: Can it Help Treat Underlying Symptoms? You should read this article to know more about CBD for Diabetic patients😉💚✅🍀

If you have relatives or friends who suffers cancer, walk with them! Our team will always encourage you to fight cancer with CBD💚

We can help you with your recommendation!!!! We’re working directly with a Doctor to help get you on the registry. DM us or email us at [email protected] for more information.

We also have great articles for you to read just visit us at www.herbalnomicsinc.org. We are still accepting volunteers please visit our page and click the sign up button.

*****na

CBD Oil for Diabetes: All You Need to Know | herbalnomics If you’ve already done some reading up on CBD, diabetes, and related symptoms, you may have heard some fairly incredulous things about the h**p-based compound a...

This Diabetes Awareness Month let them know that CBD will always support and take care of them😉💚✅🍀

If you have relatives or friends who suffers cancer, walk with them! Our team will always encourage you to fight cancer with CBD💚

We can help you with your recommendation!!!! We’re working directly with a Doctor to help get you on the registry. DM us or email us at [email protected] for more information.

We also have great articles for you to read just visit us at www.herbalnomicsinc.org. We are still accepting volunteers please visit our page and click the sign up button.

*****na

Before they are tested on something but now CBD can clearly show you the world of hope😉💚✅🍀

We can help you with your recommendation!!!! We’re working directly with a Doctor to help get you on the registry. DM us or email us at [email protected] for more information.

We also have great articles for you to read just visit us at www.herbalnomicsinc.org. We are still accepting volunteers please visit our page and click the sign up button.

*****na

Study: CBD From Ma*****na Plus Chemotherapy Tripled Cancer Survival Rates In Mice | herbalnomics Mice with pancreatic cancer treated with a combination of cannabidiol (CBD) and chemotherapy survived nearly three times longer than those treated with chemothe...

You were scared to death when you found out about your breast cancer condition until.... CBD came and rescue your life😉💚✅🍀 Live life to the fullest🤟

Read more 👉https://bit.ly/2yXjTze

We can help you with your recommendation!!!! We’re working directly with a Doctor to help get you on the registry. DM us or email us at [email protected] for more information.

We also have great articles for you to read just visit us at www.herbalnomicsinc.org. We are still accepting volunteers please visit our page and click the sign up button.

*****na